Sen. Peter Welch (D-Vt.) has introduced a bill that would ban pharmaceutical companies from restricting access to 340B drug pricing program discounts, according to a Sept. 11 press release shared with Becker’s.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
